{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:02Z","timestamp":1786119182887,"version":"build-2736575974"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/mol.0b013e3282efd0d4","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T17:57:18Z","timestamp":1236189438000},"page":"521-526","source":"Crossref","is-referenced-by-count":32,"title":["Immunomodulation of the inflammatory response in atherosclerosis"],"prefix":"10.1097","volume":"18","author":[{"given":"Johan","family":"Kuiper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs HM","family":"van Puijvelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva JA","family":"van Wanrooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"van Es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Habets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud D","family":"Hauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo JC","family":"van den Berkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210205","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1161\/01.ATV.0000245830.29764.84","article-title":"T cells in atherogenesis: for better or for worse?","volume":"26","author":"Robertson","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R2-7-20210205","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/CIRCULATIONAHA.106.656751","article-title":"Immunosuppression in atherosclerosis: mobilizing the opposition within","volume":"114","author":"Goronzy","year":"2006","journal-title":"Circulation"},{"key":"R3-7-20210205","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"R4-7-20210205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol Rev"},{"key":"R5-7-20210205","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1073\/pnas.92.3.821","article-title":"Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis","volume":"92","author":"Palinski","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-7-20210205","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.ATV.16.8.1074","article-title":"Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits","volume":"16","author":"Regnstrom","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R7-7-20210205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/08916930500050525","article-title":"Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression","volume":"38","author":"Fredrikson","year":"2005","journal-title":"Autoimmunity"},{"key":"R8-7-20210205","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/08916930601165107","article-title":"Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice","volume":"40","author":"Fredrikson","year":"2007","journal-title":"Autoimmunity"},{"key":"R9-7-20210205","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/01.ATV.20.9.2106","article-title":"Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis","volume":"20","author":"Rittershaus","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R10-7-20210205","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.fjc.0000161402.91456.70","article-title":"Vaccinating rabbits with a cholesteryl ester transfer protein (CETP) B-cell epitope carried by heat shock protein-65 (HSP65) for inducing anti-CETP antibodies and reducing aortic lesions in vivo","volume":"45","author":"Gaofu","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"R11-7-20210205","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1016\/j.vaccine.2006.03.082","article-title":"Intramuscular immunization with a DNA vaccine encoding a 26-amino acid CETP epitope displayed by HBc protein and containing CpG DNA inhibits atherosclerosis in a rabbit model of atherosclerosis","volume":"24","author":"Mao","year":"2006","journal-title":"Vaccine"},{"key":"R12-7-20210205","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa071359","article-title":"Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia","volume":"356","author":"Kastelein","year":"2007","journal-title":"N Engl J Med"},{"key":"R13-7-20210205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0021-9150(01)00418-X","article-title":"Freunds adjuvant alone is antiatherogenic in apoE-deficient mice and specific immunization against TNFalpha confers no additional benefit","volume":"158","author":"Hansen","year":"2001","journal-title":"Atherosclerosis"},{"key":"R14-7-20210205","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.atherosclerosis.2005.04.021","article-title":"Atheroprotective effect of adjuvants in apolipoprotein E knockout mice","volume":"184","author":"Khallou-Laschet","year":"2006","journal-title":"Atherosclerosis"},{"key":"R15-7-20210205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2004.11.016","article-title":"Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice","volume":"180","author":"Ohta","year":"2005","journal-title":"Atherosclerosis"},{"key":"R16-7-20210205","first-page":"1213","article-title":"Low incidence of first cardiovascular event in rheumatoid arthritis patients treated with TNF blockers","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J Rheumatol"},{"key":"R17-7-20210205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/ard.2004.023119","article-title":"Influence of antitumor necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis","volume":"64","author":"Popa","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R19-7-20210205","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/CIRCULATIONAHA.104.533463","article-title":"Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis","volume":"112","author":"Hauer","year":"2005","journal-title":"Circulation"},{"key":"R21-7-20210205","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/01.RES.0000204452.46568.57","article-title":"Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque","volume":"98","author":"Zhang","year":"2006","journal-title":"Circ Res"},{"key":"R22-7-20210205","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa033402","article-title":"Antiinterleukin-12 antibody for active Crohn's disease","volume":"351","author":"Mannon","year":"2004","journal-title":"N Engl J Med"},{"key":"R23-7-20210205","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1161\/01.ATV.0000232502.88144.6f","article-title":"IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice","volume":"26","author":"Chen","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R24-7-20210205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J Clin Invest"},{"key":"R25-7-20210205","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.21007","article-title":"Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL\/lpr mice","volume":"52","author":"Inoue","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R26-7-20210205","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.ATV.0000231527.22762.71","article-title":"Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice","volume":"26","author":"Potteaux","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R28-7-20210205","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.ATV.0000253886.44609.ae","article-title":"CCR5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice","volume":"27","author":"Braunersreuther","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R29-7-20210205","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1161\/01.ATV.0000192018.90021.c0","article-title":"HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice","volume":"25","author":"Van Wanrooij","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R30-7-20210205","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/01.ATV.0000235694.69719.e2","article-title":"Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo","volume":"26","author":"Schepers","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R31-7-20210205","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.atherosclerosis.2005.11.025","article-title":"Decreased plasma CXCL16\/SR-PSOX concentration is associated with coronary artery disease","volume":"188","author":"Sheikine","year":"2006","journal-title":"Atherosclerosis"},{"key":"R32-7-20210205","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.105.540583","article-title":"Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis","volume":"114","author":"Aslanian","year":"2006","journal-title":"Circulation"},{"key":"R33-7-20210205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2005.10.015","article-title":"Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages","volume":"188","author":"Veillard","year":"2006","journal-title":"Atherosclerosis"},{"key":"R34-7-20210205","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/01.ATV.0000255581.38523.7c","article-title":"Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis","volume":"27","author":"Dam\u00e5s","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R35-7-20210205","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat Med"},{"key":"R36-7-20210205","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.105.605121","article-title":"Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells","volume":"113","author":"Heller","year":"2006","journal-title":"Circulation"},{"key":"R37-7-20210205","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1161\/01.CIR.0000127121.16815.F1","article-title":"B7-1\/B7-2 co-stimulation regulates plaque antigen-specific T cell responses and atherogenesis in LDLr\u2212\/\u2212 mice","volume":"109","author":"Buono","year":"2004","journal-title":"Circulation"},{"key":"R38-7-20210205","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.106.683201","article-title":"CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1","volume":"115","author":"Zirlik","year":"2007","journal-title":"Circulation"},{"key":"R39-7-20210205","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/ATVBAHA.107.140566","article-title":"TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate pro-inflammatory functions of CD40L in endothelial cells","volume":"27","author":"Zirlik","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R40-7-20210205","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.bbrc.2005.11.092","article-title":"Human genetic evidence that OX40 is implicated in myocardial infarction","volume":"339","author":"Ria","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"R41-7-20210205","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng1524","article-title":"Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility","volume":"37","author":"Wang","year":"2005","journal-title":"Nat Genet"},{"key":"R42-7-20210205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.ATV.0000251007.07648.81","article-title":"Interruption of the Tnfrsf4\/Tnfsf4 (OX40\/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice","volume":"27","author":"Van Wanrooij","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R43-7-20210205","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.106.633263","article-title":"Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule","volume":"114","author":"Gotsman","year":"2006","journal-title":"Circulation"},{"key":"R44-7-20210205","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/j.vaccine.2007.02.078","article-title":"Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trials","volume":"25","author":"Mehrishi","year":"2007","journal-title":"Vaccine"},{"key":"R45-7-20210205","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.CIR.0000089083.61317.A1","article-title":"Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice","volume":"108","author":"Mallat","year":"2003","journal-title":"Circulation"},{"key":"R46-7-20210205","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/01.mol.0000182532.11512.90","article-title":"Regulatory T cell responses: potential role in the control of atherosclerosis","volume":"16","author":"Mallat","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"R47-7-20210205","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1084\/jem.194.5.629","article-title":"Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta","volume":"194","author":"Nakamura","year":"2001","journal-title":"J Exp Med"},{"key":"R48-7-20210205","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nat Med"},{"key":"R49-7-20210205","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.ATV.0000259365.31469.89","article-title":"Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis","volume":"27","author":"Mor","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R50-7-20210205","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.106.627430","article-title":"Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice","volume":"114","author":"Steffens","year":"2006","journal-title":"Circulation"},{"key":"R51-7-20210205","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N Engl J Med"},{"key":"R52-7-20210205","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0735-1097(02)02135-6","article-title":"Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions","volume":"40","author":"Harats","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R53-7-20210205","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/01.CIR.0000029750.99462.30","article-title":"Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice","volume":"106","author":"Maron","year":"2002","journal-title":"Circulation"},{"key":"R54-7-20210205","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cardiores.2004.01.028","article-title":"Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I","volume":"62","author":"George","year":"2004","journal-title":"Cardiovasc Res"},{"key":"R55-7-20210205","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.106.615609","article-title":"Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis","volume":"114","author":"Van Puijvelde","year":"2006","journal-title":"Circulation"},{"key":"R56-7-20210205","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF03401937","article-title":"Induction of neonatal tolerance to oxidized lipoprotein reduces atherosclerosis in ApoE knockout mice","volume":"6","author":"Nicoletti","year":"2000","journal-title":"Mol Med"},{"key":"R57-7-20210205","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0167-5699(00)01735-7","article-title":"NKT cells: facts, functions and fallacies","volume":"21","author":"Godfrey","year":"2000","journal-title":"Immunol Today"},{"key":"R58-7-20210205","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1073\/pnas.89.14.6506","article-title":"An NK1.1+ CD4+8\u2212 single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family","volume":"89","author":"Arase","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R59-7-20210205","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1471-4914(02)02325-0","article-title":"Immunotherapy with ligands of natural killer T cells","volume":"8","author":"Wilson","year":"2002","journal-title":"Trends Mol Med"},{"key":"R60-7-20210205","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.179.4.1285","article-title":"CD4+, NK1. 1+ T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3","volume":"179","author":"Yoshimoto","year":"1994","journal-title":"J Exp Med"},{"key":"R61-7-20210205","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1084\/jem.20030324","article-title":"Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein","volume":"198","author":"Fujii","year":"2003","journal-title":"J Exp Med"},{"key":"R62-7-20210205","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/35097097","article-title":"A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells","volume":"413","author":"Miyamoto","year":"2001","journal-title":"Nature"},{"key":"R63-7-20210205","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nm0901-1052","article-title":"The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in nonobese diabetic mice","volume":"7","author":"Hong","year":"2001","journal-title":"Nat Med"},{"key":"R64-7-20210205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.20030997","article-title":"CD1d-dependent activation of NKT cells aggravates atherosclerosis","volume":"199","author":"Tupin","year":"2004","journal-title":"J Exp Med"},{"key":"R65-7-20210205","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2003-10-3485","article-title":"Natural killer T cells accelerate atherogenesis in mice","volume":"104","author":"Nakai","year":"2004","journal-title":"Blood"},{"key":"R66-7-20210205","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/01.ATV.0000153046.59370.13","article-title":"Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions","volume":"25","author":"Aslanian","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R67-7-20210205","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/01.ATV.0000147112.84168.87","article-title":"Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient mice","volume":"24","author":"Major","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R68-7-20210205","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2353\/ajpath.2007.060188","article-title":"Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis","volume":"170","author":"VanderLaan","year":"2007","journal-title":"Am J Pathol"},{"key":"R69-7-20210205","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1194\/jlr.R500003-JLR200","article-title":"Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis","volume":"46","author":"Vanderlaan","year":"2005","journal-title":"J Lipid Res"},{"key":"R70-7-20210205","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.atherosclerosis.2005.01.046","article-title":"Identification of natural killer cells in human atherosclerotic plaque","volume":"180","author":"Bobryshev","year":"2005","journal-title":"Atherosclerosis"},{"key":"R71-7-20210205","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nature04001","article-title":"Apolipoprotein-mediated pathways of lipid antigen presentation","volume":"437","author":"Van den Elzen","year":"2005","journal-title":"Nature"},{"key":"R72-7-20210205","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/CIRCULATIONAHA.106.641407","article-title":"FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"115","author":"Nofer","year":"2007","journal-title":"Circulation"},{"key":"R73-7-20210205","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.ATV.0000254679.42583.88","article-title":"The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"27","author":"Keul","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOL.0b013e3282efd0d4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:37:03Z","timestamp":1786037823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00041433-200710000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0b013e3282efd0d4","relation":{},"ISSN":["0957-9672"],"issn-type":[{"value":"0957-9672","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}